Accuray Inc
Accuray Inc (ARAY) Expected Move
ARAY expected move through Oct 16, 2026 is 1,358.7%, with 27 days to expiration. The implied range is -$2.90 to $3.36, based on the previous trading day's options prices.
Read more
Tracking the ARAY expected move helps you see how far Accuray Inc's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Accuray Inc's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the ARAY expected move for this week's options, in real time.
The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For ARAY, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The ARAY expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Accuray Inc is unlikely to go.
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.
In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the ARAY expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Accuray Inc expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about ARAY.
ARAY Price
Drag chart to pan. Drag axes to zoom.
| Expiration | DTE | Expected move (USD) | Expected move (%) | Upper price | Lower price |
|---|---|---|---|---|---|
| Oct 16, 2026 | 27 | $3.13 | 1,358.7% | $3.36 | -$2.90 |
| Nov 20, 2026 | 62 | $3.88 | 1,684.8% | $4.11 | -$3.65 |
| Dec 18, 2026 | 90 | $3.05 | 1,326.1% | $3.28 | -$2.82 |
| Mar 19, 2027 | 181 | $1.14 | 494.6% | $1.37 | -$0.91 |
As of September 17, 2026
Know What the Market Expects From ARAY
Track the ARAY expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.
Start your 14-day free trial→